Internal Medicine · Birmingham, AL
NPI
1629489059
Since 2014
Specialty
Internal Medicine
Code 207R00000X
Group practices
5
Medicare group memberships
Hospitals
0
Hospital affiliations
5057 Pinnacle Sq
Birmingham, AL, 35235
Phone (205) 508-5300
Groups this clinician bills Medicare through
Medicare paid, 2024
$91K
1,489 services
Medicare patients, 2024
175
Average age 65
Drug cost, 2024
$859K
7,874 prescriptions
Company payments, 2025
$176
From 4 companies
Procedures and visits billed to Original Medicare, 2024
In 2024, the most common Medicare service billed by David M Hardin was code 99214 (office e&m - established), 670 times for 166 patients. In total David M Hardin billed 1,489 services in 17 codes, and Medicare paid $91K.
| Code |
|---|
Official US government data: the national provider registry and Medicare enrollment records, linked by NPI. Last update of this record: 2024-06-27.
| Setting |
|---|
| Services |
|---|
| Patients |
|---|
| Paid per service |
|---|
| Medicare paid |
|---|
| 99214 Office E&M - Established | Office | 670 | 166 | $76.11 | $51K |
| 80307 Drug Tests | Office | 605 | 162 | $60.37 | $37K |
| J1885 Injection, ketorolac tromethamine, per 15 mg | Office | 103 | 17 | $0.45 | $45.9 |
| 96372 Injection Administration | Office | 36 | 20 | $9.16 | $330 |
| 99204 Office E&M - New | Office | 21 | 21 | $81.19 | $1,705 |
By year: 2022 $109K for 1,718 services; 2023 $97K for 1,515 services; 2024 $91K for 1,489 services.
Lab tests billed to Medicare, 2024
| Test code | Tests | Patients | Paid per test | Medicare paid |
|---|---|---|---|---|
| 80307 Drug Tests | 605 | 162 | $60.37 | $37K |
Medicare prescription drug claims, 2024
In 2024, the drug David M Hardin prescribed most often to Medicare patients was Hydrocodone-Acetaminophen (Hydrocodone/Acetaminophen), with 1,368 prescriptions and refills. In total David M Hardin wrote 7,874 Medicare prescriptions that cost $859K.
| Drug | Claims | 30-day fills | Patients | Cost |
|---|---|---|---|---|
| Hydrocodone-Acetaminophen Hydrocodone/Acetaminophen | 1,368 | 1,368 | 200 | $31K |
| Oxycodone-Acetaminophen Oxycodone Hcl/Acetaminophen | 1,018 | 1,018 | 157 | $25K |
| Gabapentin Generic | 882 | 928 | 159 | $11K |
| Buprenorphine-Naloxone Buprenorphine Hcl/Naloxone Hcl | 747 | 747 | 115 | $170K |
| Tizanidine Hcl Generic | 549 | 582 | 98 | $5,995 |
| Ibuprofen Generic | 348 | 412 | 82 | $4,893 |
| Pregabalin Generic | 320 | 332 | 62 | $8,434 |
| Oxycodone Hcl Generic | 275 | 275 | 38 | $3,760 |
| Cyclobenzaprine Hcl Generic | 268 | 286 | 62 | $3,082 |
| Methocarbamol Generic | 254 | 268 | 47 | $2,535 |
| Buprenorphine Hcl Generic | 191 | 192 | 43 | $13K |
| Tramadol Hcl Generic | 152 | 152 | 29 | $1,190 |
| Baclofen Generic | 118 | 130 | 20 | $1,184 |
| Xtampza Er Oxycodone Myristate | 103 | 103 | Under 11 | $68K |
| Zubsolv Buprenorphine Hcl/Naloxone Hcl | 90 | 91 | 22 | $66K |
Brand drugs: 603 claims; generic drugs: 7,271 claims; opioid claims: 3,216.
Money and other things of value reported by the companies
In 2025, drug and medical device companies paid David M Hardin $176 ($176 in general payments such as food, travel and fees) from 4 companies. The largest payer was Braeburn Inc. with $94.77.
Official US government data on Original Medicare services, Medicare prescription drug plans and the payments drug and device companies must report. Services with fewer than 11 patients and drugs with fewer than 11 claims are not published. Procedure codes are shown by number with their public category.